daunorubicin has been researched along with flurazepam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cordeiro-da-Silva, A; de Castro, B; Gameiro, P; Lima, SA; Tavares, J | 1 |
1 review(s) available for daunorubicin and flurazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for daunorubicin and flurazepam
| Article | Year |
|---|---|
Flurazepam inhibits the P-glycoprotein transport function: an insight to revert multidrug-resistance phenotype.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Multiple; Flurazepam; Humans; Phenotype | 2008 |